血管閉合器械市場：依產品類型、入路方式、孔徑、最終用戶及地區分類

預計到 2026 年，血管閉合裝置市場規模將達到 16.302 億美元，到 2033 年將達到 25.02 億美元。預計從 2026 年到 2033 年，該市場將以 6.3% 的複合年成長率成長。

血管閉塞裝置有助於在心血管手術（例如血管造影術和血管成形術）後封閉動脈穿刺部位。它們透過機械或生物途徑促進自發性凝血，從而止住穿刺部位的出血。隨著全球介入性心臟病學和放射學手術數量的不斷增加，血管閉塞裝置的使用也日益普及。與手動壓迫相比，血管閉塞裝置因其能提高患者舒適度、縮短住院時間和降低併發症發生率，已成為血管通路部位管理的重要組成部分。

市場動態

受人口結構變化和技術進步等多種因素的共同影響，全球血管閉合器械市場正經歷顯著成長。其中一個主要促進因素是老年人口的不斷成長，老年人由於生理老齡化而更容易患上心血管疾病。隨著老年人口的成長，心血管疾病的發生率也隨之上升，導致對用於診斷和術後治療的有效血管閉合器械的需求增加。同時，整個醫療領域正朝著微創手術（MIS）的方向顯著轉變。與傳統開放性手術相比，微創手術可降低感染風險、縮短住院時間並加速患者復原。血管閉合器械在這些手術中發揮著至關重要的作用，它們能夠快速止血、縮短下床活動時間並提高患者舒適度。

器械技術的進步至關重要，目前正在研發的器械能夠提供更高的療效並降低術後併發症的風險。設計和材料的改進提高了密封性能，並使產品能夠適應不同的解剖結構和穿刺尺寸。然而，這些先進器械的高昂成本可能成為其廣泛應用的障礙。某些醫療保健系統不予報銷進一步加劇了這個問題，使患者難以獲得這些技術。雖然目前存在一些止血替代方法，例如手動壓迫，但這些方法通常會導致更長的恢復期和更高的併發症風險，因此，引入先進的血管閉合器械具有重要意義。

市場機會眾多，尤其是在醫療保健投資不斷成長、醫療基礎設施不斷完善的新興經濟體。新型器械（包括採用可生物分解材料的器械）的持續研發蘊藏著巨大的潛力。這些器械常用於經導管主動脈瓣置換術(TAVR) 等複雜手術。總體而言，儘管成本和報銷方面的挑戰依然存在，但血管閉合器械的優勢，包括技術進步和微創手術 (MIS) 需求的不斷成長，有望繼續推動市場成長。

例如，2022 年 1 月，專注於提供創新醫療解決方案以改善患者預後的醫療技術公司 Hemonetics 簽署了一項最終協議，收購了生產血管閉合系統的私人公司Cardiva Medical。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數介紹了全球血管閉合裝置市場主要參與者的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
• 這份全球血管閉塞裝置市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球血管閉合裝置市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
    • 老年人口增加
    • 血管成形術的推廣
    • 心血管疾病盛行率增加
    • 對微創手術的需求日益成長
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景

第4章 全球血管閉合器材市場：依產品類型分類，2021-2033年

• 被動血管閉塞裝置
• 主動血管閉塞裝置
• 體外止血裝置

第5章 全球血管閉合器械市場：以入路方式分類，2021-2033年

• 股動脈
• 半徑

第6章 全球血管閉合器械市場：依孔徑分類，2021-2033年

• 小路
• 大直徑

第7章 全球血管閉合器械市場：依最終用戶分類，2021-2033年

• 醫院
• 門診手術中心
• 其他

第8章 全球血管閉合器材市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第9章 競爭情勢

• Abbott
• Cardiva Medical Inc.
• Terumo Corporation
• Johnson & Johnson Services Inc.
• B. Braun SE
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• ConforMIS, Inc.
• Medtronic
• Transluminal Technologies LLC
• Cardinal Health
• Teleflex Incorporated
• Vasorum Ltd.
• Tricol Biomedical
• Merit Medical Systems, Inc.
• Stryker

第10章

• 調查方法
• 關於本公司

Vascular Closure Device Market is estimated to be valued at USD 1,630.2 Mn in 2026 and is expected to reach USD 2,500.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Vascular closure devices help seal arterial punctures after a cardiovascular procedure such as angiography or angioplasty. They help stop bleeding at the puncture site by accelerating natural clotting through mechanical or biological means. The global usage of vascular closure devices has been increasing with growth in interventional cardiology and radiology procedures worldwide. Improved patient comfort, reduced hospital stay times, and lower complication rates compared to manual compression methods have made vascular closure devices an integral part of vascular access site management.

Market Dynamics

The global vascular closure device market is growing substantially, propelled by a confluence of factors ranging from demographic shifts to technological progress. A significant contributor to this growth is the rising geriatric population which is more susceptible to cardiovascular diseases due to physiological aging. As the elderly population grows, so does the incidence of cardiovascular conditions, thereby increasing the demand for effective vascular closure devices following diagnostic and therapeutic procedures. Simultaneously, a notable shift towards minimally invasive surgeries (MIS) across the healthcare sector. MIS procedures reduce the risk of infection, shorten hospital stays, and speed up patient recovery times compared to traditional open surgeries. Vascular closure devices play a key role in these procedures by providing rapid hemostasis, reducing time to ambulation, and enhancing patient comfort.

Advancements in device technology have also been pivotal, leading to devices that offer greater efficacy and a reduced risk of post-procedure complications. Enhanced designs and materials have yielded products with improved sealing capabilities and compatibility with various anatomies and puncture sizes. On the other side of the spectrum, the high costs associated with these advanced devices can act as a barrier to their widespread adoption. The lack of reimbursement in certain healthcare systems further exacerbates this issue, making it challenging for patients to access these technologies. While existing alternatives for achieving hemostasis, such as manual compression, exist, they often come with longer recovery times and elevated risks of complications, thereby providing an opening for the adoption of advanced vascular closure devices.

The market is ripe with opportunities, especially within emerging economies that are currently witnessing increased healthcare investments and enhancements to their healthcare infrastructure. The significant potential in the ongoing development of novel devices, including those made from biodegradable materials, commonly used in complex procedures like transcatheter aortic valve replacement (TAVR).Overall, while challenges like cost and reimbursement issues persist, the benefits of vascular closure devices, including the advancements in technology and rising demands for MIS, are likely to continue to drive market growth.

For instance, in January 2022, Haemonetics Corporation, a medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., a manufacturer of vascular closure systems.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global vascular closure device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Cardiva Medical Inc., Terumo Corporation, Johnson & Johnson Services Inc., B. Braun SE, Biotronik SE & Co. KG, MicroPort Scientific Corporation, ConforMIS, Inc., Medtronic, Transluminal Technologies LLC, Cardinal Health, Teleflex Incorporated, Vasorum Ltd., Tricol Biomedical, Merit Medical Systems, Inc., Stryker
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global vascular closure device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular closure device market.

Market Segmentation

• By Product Type (Revenue, USD Mn, 2021 - 2033)
• Passive Vascular Closure Devices
• Active Vascular Closure Devices
• External Hemostatic Devices
• By Access (Revenue, USD Mn, 2021 - 2033)
• Femoral
• Radial
• By Hole Size (Revenue, USD Mn, 2021 - 2033)
• Small Hole
• Large Hole
• By End User (Revenue, USD Mn, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Others
• By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top companies in Global Vascular Closure Device Market
• Abbott
• Cardiva Medical Inc.
• Terumo Corporation
• Johnson & Johnson Services Inc.
• B. Braun SE
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• ConforMIS, Inc.
• Medtronic
• Transluminal Technologies LLC
• Cardinal Health
• Teleflex Incorporated
• Vasorum Ltd.
• Tricol Biomedical
• Merit Medical Systems, Inc.
• Stryker

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Vascular Closure Device Market, By Product Type
  • Vascular Closure Device Market, By Access
  • Vascular Closure Device Market, By Hole Size
  • Vascular Closure Device Market, By End User
  • Vascular Closure Device Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
    • Rising geriatric population
    • The proliferation of angioplasty procedures
    • The increasing prevalence of cardiovascular diseases incidence
    • Increasing demand for minimally invasive surgeries
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Vascular Closure Device Market, By Product Type, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Passive Vascular Closure Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• Active Vascular Closure Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• External Hemostatic Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

5. Global Vascular Closure Device Market, By Access, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Femoral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• Radial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

6. Global Vascular Closure Device Market, By Hole Size, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Small Hole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• Large Hole
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

7. Global Vascular Closure Device Market, By End User, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

8. Global Vascular Closure Device Market, By Region, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Country, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country 2021 - 2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Access, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hole Size, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Abbott
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardiva Medical Inc.
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Johnson & Johnson Services Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• B. Braun SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biotronik SE & Co. KG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MicroPort Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ConforMIS, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Transluminal Technologies LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vasorum Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Tricol Biomedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merit Medical Systems, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Stryker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us